BUY Target: A$0.77. Investment Highlights



Similar documents
AUS Update 1 16 October Highfield Resources Limited Luke Smith PILGRIMAGE TO PAMPLONA. BUY Target: A$0.

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

Investment Outlook. and The Attraction of Dividends CHB CONFERENCE CANACCORD GENUITY

Investment highlights Management provided safe 2013 guidance of 33,000 boe/d, which was substantially lower than our 41,000 boe/d expectation.

BUY. Target: $0.90. Lifesciences - Biotechnology. Live and Let Dye. Investment highlights

Metals X Limited Luke Smith

BUY Target: A$0.90. Lifesciences - Biotechnology. Trophon Cleans Up

Palangana expansion fully permitted; Burke Hollow receives disposal well permit. Associate: Michael Wichterle, MBA,

Year-end Dec 2013A 2014E 2015E 2016E Key data. # Priced at market close, 29/09/14

Trends and Technology A Capital Markets Perspective

2015 Budget RPM Continues its Focus on High Potential Targets

Oracle Corp. (ORCL) Sounds like we should forget about move to subscription accounting. The Goldman Sachs Group, Inc.

Petrel Energy Ltd. This report is intended for Unauthorized redistribution of this report is prohibited.

Closed-end fund update

DO WE NEED MORE STORAGE IN EUROPE?

DATRON AG. Investor day supports our positive view. Buy (Buy) EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015

Kingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3.

Why ECB QE is Negative for Commodities. Investment Research & Advisory. Deltec International Group

EQUITY RAISING ANNOUNCEMENT

CONVERTIBLE DEBENTURES A PRIMER

For Required Non-U.S. Analyst and Conflicts Disclosures, please see page 8. Exhibit 1: Average 3mo/6mo/1yr returns following a federal election

Overview of the Canadian Hedge Fund Industry & Common Traits of Best Fund Managers

Gujarat State Petronet Ltd. INR 135

Global Markets Research COMMONWEALTH PROGRAMS. BUSINESS AS USUAL SCENARIO (% of GDP) UNDERLYING BUDGET BALANCE (% of GDP)

Confirmation Code:

Ituran Location & Control Ltd. In-line Quarter, Big Dividend, Maintain Outperform

Clime Capital Limited (CAM)

ANZ ETFS S&P/ASX 300 HIGH YIELD PLUS ETF. (ASX Code: ZYAU)

Through the Snow, Job Market Plows Ahead

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

BUY Target: 215p YOUR HOST: K3. From value to growth stock. Raising price target to 215p

euromicron AG Corrections to financial statements Hold EUR

20% Resource Increase at Wiluna's Centipede and Millipede Deposits

Bright Smart (1428 HK)

INVESTMENT CASE FULLY INTACT

European Freight Forwarding Index

OptimizeRx OPRX. Buy. Platform Potential Continues to Grow $0.87 $4.00. Refer to the last two pages of this report for Disclosures

BDI BioEnergy Intern Neutral. Activity level in Q3 might not support FY estimates

FIRST CAPITAL. Sound 2014 results and attractive dividend. Buy (maintained) Company Update

UBS AG ANNOUNCEMENT. Proposed Issue of 15,000,000 European Style Index Put Warrants relating to the Hang Seng Index

SK Networks ( KS)

Daily Close Above Would Signal More Protracted Retracement Phase

Rating Action: Moody's upgrades Scottish Widows' and Clerical Medical's subordinated debt ratings to Baa1(hyb); outlook stable

Rating Action: Moody's changes Nexteer's Ba1 ratings outlook to positive Global Credit Research - 24 Nov 2015

Manhattan Office Property Price Index August 4, 2011 DJIA: RMZ: 10-Yr Treasury Note:

CEWE Stiftung & Co. KGaA

Thinking Ahead: Breaking Down FINRA s Revised Proposed Fixed-Income Research Rule

Perth Mint Gold (PMGOLD)

SECOND QUARTER 2015 CONFERENCE CALL & WEBCAST

QE, Credit Markets and Bubbles

Private drilling fluid technology service leader

Just Energy Income Fund

CLIENT RELATIONSHIP DISCLOSURE STATEMENT

Strategic Research: Contracts For Difference

Trxade Group, Inc. (TCQB: TRXD): Record Revenues in Q3

Recall Holdings Limited 31 December 2013 Trading Update

ANZ ETFS S&P/ASX 100 ETF. (ASX Code: ZOZI)

Master Limited Partnerships (MLPs)

Rating Action: Moody's assigns Aaa to mortgage covered bonds of Raiffeisen- Landesbank Steiermark

Tabcorp Holdings Limited 2011/12

The Volcker Rule. Implications for the FX Market

Rating Action: Moody's assigns Aaa.br rating to Duke's BRL479 million debentures; outlook stable

The Merchant Securities FTSE 100. Hindsight II Note PRIVATE CLIENT ADVISORY

Background information. Changes in the shareholder structure and balance sheet. Contract with Google prolonged for two years

Financials and valuation Year end: 31 December Price Performance. Source: Company accounts/investec Securities estimates

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

Investing in Uranium Companies

Rating Action: Moody's reviews for downgrade the ratings of MBIA Inc. and of its lead insurance subsidiaries Global Credit Research - 21 Mar 2013

Exhibit 1: Financial summary of First Tractor in 1H12-1H14 1H12 2H12 1H13 2H13 1H14 (% YoY)

SOHO China (410) Buy Nov 20, Company update. 4 Acquisitions within 6 Months. Samson Man, CFA (852) samson.man@firstshanghai.com.

Commodities. Precious metals as an asset class. April What qualifies as an asset class? What makes commodities an asset class?

Nasdaq Then and Now ECONOMIC RESEARCH. Robert Kavcic, Senior Economist April 24, Market Performance as of April 24, 2015

BDI BioEnergy Internat Buy

Property Values Hold Their Ground

How To Understand The Performance Of An International Consulting Firm

Invast Financial Services

Annual Financial Results Presentation for year ended 30 June October 2014

MATELAN Research. Intelligent Transportation Systems MEGATRENDS DRIVE MARKET GROWTH FINANCIALS ACCELERATING IVU AND INIT SHOW HIGHEST UPSIDES

2014 FIRST QUARTER RESULTS CONFERENCE CALL. May 15th, 2014

Contango MicroCap Ltd (CTN)

GAIL (India) Ltd. INR 346

Morning Buzz. Research Picks INDIA. India IT Services: Mixed quarter from Accenture. 21 December 2015

TABCORP HALF YEAR RESULTS PRESENTATION

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

Managing FX Risk when trading with Australia. Mark Coulam Senior Manager, Treasury Solutions.

ISSUE OF US$450 MILLION 6.1% GUARANTEED BONDS DUE 2025

Update following the publication of the Bank of England Stress Test. 16 December 2014

IPH LIMITED IPH LAUNCHES A$60 MILLION UNDERWRITTEN INSTITUTIONAL PLACEMENT AND SHARE PURCHASE PLAN

Sedgman enters agreement to acquire MDM Engineering

MSCI CHINA AND USA INTERNET TOP 50 EQUAL WEIGHTED INDEX

Deutsche Bank Global Transaction Banking. What DR investors are buying: An analysis of investment drivers for depositary receipts

TRADING GERMAN POWER BY USING A CLIMATE SPREAD SIGNAL

CLSA ASIA-PACIFIC SECURITIES DEALING SERVICES: AUSTRALIA MARKET ANNEX

Tetragon Financial Group Limited ( TFG )

ANZ ETFS PHYSICAL US DOLLAR ETF. (ASX Code: ZUSD)

Seven Generations Energy Ltd. 6 BUY. Equity Research VII-TSX. Kakwa acquisition expands Nest inventory. Last: C$25.10 July 7, 2016 Target: C$31.

Empresaria (EMR.L) Empressive finish to the year

Invast Financial Services Pty Ltd. Financial Services Guide (FSG) For Equities, Spot Forex & CFDs

Terrafina. Equity Research. Terra kicks off acquisition spree with US$108m purchase. BTG Pactual Global Research. Latin America

Transcription:

AUS Update 1 Tiger Resources Limited Luke Smith +61 3 8688 9136 luke.smith@canaccord.com.au TGS : ASX BUY Target: A$0.77 Gary Watson +61 2 9263 2711 gary.watson@canaccord.com.au COMPANY STATISTICS: Share Price (A$) 0.34 1 Year Hi-Lo (A$) 0.46-0.16 Market Cap (A$m) 281 Issued Shares (m) 839 Options (various) 11 Cash (31/03/14) US$11m Debt (31/03/14) US$73m Major Shareholders Antares Capital Partners 6.9% EARNINGS SUMMARY: Dec Yr End 2014e 2015e 2016e Copper Prod n (t) 46,481 46,119 49,518 AISC US$/lb 1.14 0.93 0.94 Copper Price US$/lb 312 325 315 EBITDA (US$m) 149.0 222.3 241.4 EV/EBITDA* 2.9x 1.3x 0.4x P/CF* 3.0x 2.1x 2.6x NPAT (US$m) 81.5 113.0 146.8 EPS* (A$) $0.06 $0.09 $0.12 PER* 5.3x 3.8x 2.9x Source: Canaccord Genuity estimates SHARE PRICE PERFORMANCE: Source: Interactive Data Corporation COMPANY DESCRIPTION: Tiger Resources Ltd is an Australian-based company focused on the discovery and development of high grade copper/ cobalt deposits in the world-renowned copper belt in the DRC. TGS has established itself as a copper producer with excellent growth potential after making the transition from an explorer. All amounts are in AUD unless otherwise noted. Metals and Mining -- Base Metals CATHODE COMMENCES Investment Perspective Tiger Resources (TGS) has announced the US$161m construction of the 25ktpa Kipoi SXEW plant has been completed and so has commissioning, delivering first copper cathode within budget and on time. This is an enviable achievement for a mining project and in particular given Kipoi s location, in central southern Africa. We forecast TGS will produce more than 53kt of copper in the next four quarters to MarQ 15 and will do so with almost no mining. This compound effect of elevated revenue with lower operating costs is why we continue to view TGS as our most preferred copper exposure and maintain our BUY rating. Investment Highlights TGS has completed commissioning of the SXEW plant at Kipoi in the DRC. It is a major milestone for the company and signals the end of the intensive capital investment over the past sixteen months. TGS has stated it expects the SXEW plant to reach full production within three months and at which time it will be able to ascertain the full capability of the nominal 25ktpa plant. First cathode effectively mitigates construction and commissioning risk for TGS. This was the largest risk for TGS over the past six months as working capital was drawn down to complete construction. The change in working capital will now rapidly reverse as cathode production ramps up over the next few months. We anticipate the first look into how the ramp up has gone will be the JunQ report, which will be released late July. Importantly, first cathode does not signal the end of HMS copper concentrate production. We forecast TGS to produce both copper cathode and copper in concentrate for the next four quarters, totalling 53kt of copper, of which we estimate 21kt to be cathode. In conjunction with the step change in production, will be the cessation of mining. We forecast this to result in US$279m of revenue offset by only US$69m of operating costs for the four quarters to MarQ 2015. Furthermore we forecast strong EPS growth for the next three financial years, doubling from 3c (FY13) to 6c in the current financial year (FY14) and doubling again by 2016. This earnings and cashflow generation of the long life (CGAu current est. 12yrs) Kipoi copper project is why we continue to view TGS as the preferred copper producer on the ASX. Maintaining our BUY rating and Target Price of A$0.77 Our target price is derived using a DCF valuation (NPV 8% ) of the Kipoi Copper Project as part of a sum of the parts valuation for TGS. Our Target Price remains unchanged at A$0.77. Canaccord Genuity (Australia) Limited is the Australian affiliate of global capital markets group Canaccord Genuity Group Inc.. (CF : TSX CF. : LSE) The recommendations and opinions expressed in this research report accurately reflect the Analyst s personal, independent and objective views about any and all the designated investments and relevant issuers discussed herein. For important information, please see the Disclosures at the end of this document.

AUS Update 2 FINANCIAL SUMMARY Tiger Resources Limited ASX:TGS Analyst Luke Smith Rating: BUY Date: 26/05/2014 Price Target: $0.77 Year End: December Market Information Company Description Share Price A$ 0.34 Tiger Resources Ltd is an Australian-based company focused on the discovery and development of high grade Market Capitalisation A$m 281.0 copper/ cobalt deposits in the world-renowned copper belt in the DRC. TGS has established itself as a copper 12 Month Hi-Lo A$ 0.46-0.16 producer with excellent growth potential after making the transition from an explorer. Issued Capital m 838.90 Options & Performance Shares m 11.46 Fully Diluted m 850.36 Profit & Loss (US$m) 2013a 2014e 2015e 2016e 2017e Revenue 193.1 230.7 306.9 340.4 343.2 Operating Costs 82.1 69.1 65.7 78.7 116.0 Valuation A$m Risk Adj. A$/share Royalties 7.3 8.8 11.8 13.0 13.1 Kipoi (60% equity) 8% 626.1 100% 0.74 Corporate & O'heads 6.9 5.1 5.1 5.2 5.3 Kipoi Exploration 62.3 50% 0.07 Exploration (Expensed) 3.2 2.1 2.1 2.1 2.1 Sase Project 18.6 50% 0.02 EBITDA 74.6 149.0 222.3 241.4 206.5 Cash 13.9 0.02 Dep'n 20.7 29.5 63.0 38.7 54.6 Debt (60% equity) (43.8) (0.05) EBIT 54.0 119.6 159.3 202.7 151.9 Investments 0.8 0.00 Net Interest -0.5-3.2 2.1 7.0 14.7 Options 0.0 0.00 Tax -20.0-34.9-48.4-62.9-50.0 Less: Corporate & O'heads (24.2) (0.03) NPAT 33.4 81.5 113.0 146.8 116.6 TOTAL NAV/ Price Target 653.6 0.77 Abnormals 0.0 0.0 0.0 0.0 0.0 Price:NAV 0.44x NPAT (reported) 33.4 81.5 113.0 146.8 116.6 Cash Flow (US$m) 2013a 2014e 2015e 2016e 2017e Assumptions 2014e 2015e 2016e 2017e Cash Receipts 166.9 234.2 306.9 340.4 343.2 Copper Price* (US$/t) 6,584 7,093 6,875 6,875 Cash paid to suppliers & employees -84.4-72.4-81.4-96.7-134.2 * Received Tax Paid -21.5-15.7-23.2-78.6-50.0 AUD:USD 0.92 0.93 0.90 0.85 Net Interest paid -1.4-3.9-0.3 0.0 0.0 Operating Cash Flow 59.7 142.1 202.0 165.1 159.0 Valuation Sensitivity Exploration and Evaluation -3.6-2.0-2.0-2.0-2.0 $1.20 Capex -127.0-77.4-111.1-51.1-6.2 Other -31.0-7.0 2.4 7.0 14.7 $1.00 Investing Cash Flow -161.6-86.4-110.7-46.1 6.4 Debt Drawdown (repayment) 66.9-46.4-27.1-0.9 0.0 $0.80 Share capital 41.0 0.0 0.0 0.0 0.0 Dividends 0.0 0.0 0.0 0.0 0.0 $0.60 Financing Expenses -2.6 0.0 0.0 0.0 0.0 Financing Cash Flow 105.3-46.4-27.1-0.9 0.0 $0.40 Opening Cash 34.5 37.6 47.1 111.3 229.4 Increase / (Decrease) in cash 3.4 9.3 64.2 118.2 165.5 $0.20 FX Impact -0.2 0.2 0.0 0.0 0.0 $0.00 Closing Cash 37.6 47.1 111.3 229.4 394.9-30% -20% -10% 0% 10% 20% 30% Balance Sheet (US$m) 2013a 2014e 2015e 2016e 2017e Copper Price US$ Exchange Rate Discount rate OPEX Cash + S/Term Deposits 37.6 47.1 111.3 229.4 394.9 Other current assets 51.8 58.5 73.7 81.7 56.6 Production Metrics 2013a 2014e 2015e 2016e Current Assets 89.4 105.6 184.9 311.1 451.5 Kipoi (60% equity) Property, Plant & Equip. 140.7 188.6 236.6 249.0 200.6 Cu in Conc. 41,266 32,171 6,699 0 Exploration & Develop. 71.4 65.4 61.4 57.4 50.4 Cu Cathode 0 14,310 39,420 49,518 Other Non-current Assets 1.4 1.4 1.4 1.4 1.4 Total Cu Production 41,266 46,481 46,119 49,518 Payables 47.0 46.8 61.4 51.1 51.5 All-in Sustaining Costs (US$/lb) 1.60 1.14 0.93 0.94 Short Term debt 49.6 27.1 0.9 0.0 0.0 (payable) Long Term Debt 24.8 0.9 0.0 0.0 0.0 Other Liabilities 3.3 32.7 62.2 62.7 32.3 Net Assets 168.6 248.5 360.0 505.1 620.1 Reserves & Resources Mt Grade (%) Cu (kt) Shareholders Funds 179.2 179.2 179.2 179.2 179.2 Kipoi (60% equity) Reserves 13.8 14.7 14.7 14.7 14.7 Resources Measured 8.0 2.8 223 Retained Earnings -72.6-26.7 38.1 123.1 190.0 Indicated 53.0 1.2 625 Total Equity 168.6 248.5 360.0 505.1 620.1 Inferred 12.3 1.1 133 Total 73.3 1.3 981 Ratios & Multiples 2013a 2014e 2015e 2016e 2017e Reserves Proven 7.5 2.9 215 EBITDA Margin 39% 65% 72% 71% 60% Probable 35.9 1.3 481 EV/EBITDA* 6.8x 2.9x 1.3x 0.4x -0.9x Total 43.4 1.6 696 Op. Cashflow/Share* (A$) $0.05 $0.11 $0.16 $0.13 $0.13 P/CF* 7.2x 3.0x 2.1x 2.6x 2.5x Directors & Management EPS* (A$) $0.03 $0.06 $0.09 $0.12 $0.10 Name Position EPS Growth 189% 144% 38% 33% -16% Neil Fearis NE Chairman PER* 12.9x 5.3x 3.8x 2.9x 3.4x Brad Marwood Managing Director *Equity basis Stephen Hills Finance Director Dividend Per Share $0.00 $0.00 $0.00 $0.00 $0.00 David Constable NE Director Dividend Yield 0% 0% 0% 0% 0% Michael Griffiths NE Director ROE 20% 33% 31% 29% 19% ROIC 17% 47% 62% 78% 57% Debt/Equity 15% 0% 0% 0% 0% Substantial Shareholders Shares (m) % Net Interest Cover 39.4x 30.6x 514.9x nm nm Antares Capital Partners 58.2 6.9% Book Value/share $0.21 $0.30 $0.43 $0.60 $0.74 BlackRock Group 40.6 4.8% Price/Book Value 1.6x 1.1x 0.8x 0.6x 0.5x Change in Target Price Source: Company reports & Canaccord Genuity estimates * TGS Pro-rata share (60% ownership of Kipoi)

AUS Update 3 INVESTMENT RISKS TGS is exposed to a number of risks including: Country risk: the DRC is a developing country with a poor reputation. Nevertheless the last ten years have seen billions of dollars invested in the Katanga Province. Most of the large copper players have an interest in the region. Commodity price risk: the revenues TGS will derive through the sale of copper concentrate and copper cathodes expose the potential income to commodity price risk. Commodity prices fluctuate and are affected by many factors beyond the control of TGS. Such factors include supply and demand fluctuations for copper, technological advancement, forward selling activities and macro-economic factors. Infrastructure risk: i.e. the risk that adequate infrastructure (access, power and water) is not readily available to develop the project. With regards to the SX-EW plant, the operation requires about 3,000 kwh/t of copper produced. The electro-winning process also requires a reliable and steady current to yield high quality copper cathodes. Capital expenditure risk: i.e. the risk that capital costs exceed budget and/or exhaust available funding before completion of phase 2 of Stage 2 at Kipoi. Operational cost risk: an increase in operating costs will reduce the profitability and free cash generation of the project. Management and labour risk: an experienced and skilled management team is essential to the successful development and operation of the project.

AUS Update 4 APPENDIX: IMPORTANT DISCLOSURES Analyst Certification: Each authoring analyst of Canaccord Genuity whose name appears on the front page of this research hereby certifies that (i) the recommendations and opinions expressed in this research accurately reflect the authoring analyst s personal, independent and objective views about any and all of the designated investments or relevant issuers discussed herein that are within such authoring analyst s coverage universe and (ii) no part of the authoring analyst s compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by the authoring analyst in the research. Analysts employed outside the US are not registered as research analysts with FINRA. These analysts may not be associated persons of Canaccord Genuity Inc. and therefore may not be subject to the NASD Rule 2711 and NYSE Rule 472 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account. Compendium Report: Site Visit: If this report covers six or more subject companies, it is a compendium report and Canaccord Genuity and its affiliated companies hereby direct the reader to the specific disclosures related to the subject companies discussed in this report, which may be obtained at the following website (provided as a hyperlink if this report is being read electronically) http://disclosures.canaccordgenuity.com/en/pages/default.aspx; or by sending a request to Canaccord Genuity Corp. Research, Attn: Disclosures, P.O. Box 10337 Pacific Centre, 2200-609 Granville Street, Vancouver, BC, Canada V7Y 1H2; or by sending a request by email to disclosures@canaccordgenuity.com. The reader may also obtain a copy of Canaccord Genuity s policies and procedures regarding the dissemination of research by following the steps outlined above. An analyst has visited Tiger Resources Limited's material operations in the Democratic Republic of Congo. Reimbursement was received from the issuer for the related travel costs. Price Chart:* Distribution of Ratings: Global Stock Ratings (as of 31 March 2014) Canaccord Genuity Ratings System: Risk Qualifier: Coverage Universe IB Clients Rating # % % Buy 580 58.7% 37.1% Speculative Buy 43 4.4% 55.8% Hold 317 32.1% 13.2% Sell 45 4.6% 4.4% 988* 100.0% *Total includes stocks that are Under Review BUY: The stock is expected to generate risk-adjusted returns of over 10% during the next 12 months. HOLD: The stock is expected to generate risk-adjusted returns of 0-10% during the next 12 months. SELL: The stock is expected to generate negative risk-adjusted returns during the next 12 months. NOT RATED: Canaccord Genuity does not provide research coverage of the relevant issuer. Risk-adjusted return refers to the expected return in relation to the amount of risk associated with the designated investment or the relevant issuer. SPECULATIVE: Stocks bear significantly higher risk that typically cannot be valued by normal fundamental criteria. Investments in the stock may result in material loss.

AUS Update 5 Canaccord Genuity Research Disclosures as of Company Disclosure Tiger Resources Limited 1A, 2, 4, 7, 8 1 The relevant issuer currently is, or in the past 12 months was, a client of Canaccord Genuity or its affiliated companies. During this period, Canaccord Genuity or its affiliated companies provided the following services to the relevant issuer: A. investment banking services. B. non-investment banking securities-related services. C. non-securities related services. 2 In the past 12 months, Canaccord Genuity or its affiliated companies have received compensation for Corporate Finance/Investment Banking services from the relevant issuer. 3 In the past 12 months, Canaccord Genuity or any of its affiliated companies have been lead manager, co-lead manager or co-manager of a public offering of securities of the relevant issuer or any publicly disclosed offer of securities of the relevant issuer or in any related derivatives. 4 Canaccord Genuity acts as corporate broker for the relevant issuer and/or Canaccord Genuity or any of its affiliated companies may have an agreement with the relevant issuer relating to the provision of Corporate Finance/Investment Banking services. 5 Canaccord Genuity or one or more of its affiliated companies is a market maker or liquidity provider in the securities of the relevant issuer or in any related derivatives. 6 In the past 12 months, Canaccord Genuity, its partners, affiliated companies, officers or directors, or any authoring analyst involved in the preparation of this research has provided services to the relevant issuer for remuneration, other than normal course investment advisory or trade execution services. 7 Canaccord Genuity or one or more of its affiliated companies intend to seek or expect to receive compensation for Corporate Finance/Investment Banking services from the relevant issuer in the next six months. 8 The authoring analyst, a member of the authoring analyst s household, or any individual directly involved in the preparation of this research, has a long position in the shares or derivatives, or has any other financial interest in the relevant issuer, the value of which increases as the value of the underlying equity increases. 9 The authoring analyst, a member of the authoring analyst s household, or any individual directly involved in the preparation of this research, has a short position in the shares or derivatives, or has any other financial interest in the relevant issuer, the value of which increases as the value of the underlying equity decreases. 10 Those persons identified as the author(s) of this research, or any individual involved in the preparation of this research, have purchased/received shares in the relevant issuer prior to a public offering of those shares, and such person s name and details are disclosed above. 11 A partner, director, officer, employee or agent of Canaccord Genuity or its affiliated companies, or a member of his/her household, is an officer, or director, or serves as an advisor or board member of the relevant issuer and/or one of its subsidiaries, and such person s name is disclosed above. 12 As of the month end immediately preceding the date of publication of this research, or the prior month end if publication is within 10 days following a month end, Canaccord Genuity or its affiliated companies, in the aggregate, beneficially owned 1% or more of any class of the total issued share capital or other common equity securities of the relevant issuer or held any other financial interests in the relevant issuer which are significant in relation to the research (as disclosed above). 13 As of the month end immediately preceding the date of publication of this research, or the prior month end if publication is within 10 days following a month end, the relevant issuer owned 1% or more of any class of the total issued share capital in Canaccord Genuity or any of its affiliated companies. 14 Other specific disclosures as described above. Canaccord Genuity is the business name used by certain wholly owned subsidiaries of Canaccord Genuity Group Inc., including Canaccord Genuity Inc., Canaccord Genuity Limited, Canaccord Genuity Corp., and Canaccord Genuity (Australia) Limited, an affiliated company that is 50%-owned by Canaccord Genuity Group Inc. The authoring analysts who are responsible for the preparation of this research are employed by Canaccord Genuity Corp. a Canadian broker-dealer with principal offices located in Vancouver, Calgary, Toronto, Montreal, or Canaccord Genuity Inc., a US broker-dealer with principal offices located in Boston, New York, San Francisco and Houston a US broker-dealer with principal offices located in New York or Canaccord Genuity Limited., a UK broker-dealer with principal offices located in London and Edinburgh (UK), or Canaccord Genuity (Australia) Limited, an Australian broker-dealer with principal offices located in Sydney and Melbourne. The authoring analysts who are responsible for the preparation of this research are employed by Canaccord Genuity Corp. a Canadian broker-dealer with principal offices located in Vancouver, Calgary, Toronto, Montreal, or Canaccord Genuity Inc., a US broker-dealer with principal offices located in New York, Boston, San Francisco and Houston, or Canaccord Genuity Limited., a UK broker-dealer with principal offices located in London (UK) and Dublin (Ireland), or Canaccord Genuity (Australia) Limited, an Australian broker-dealer with principal offices located in Sydney and Melbourne. Canaccord Genuity and its affiliated companies may have a Corporate Finance/Investment Banking or other relationship with the issuer that is the subject of this research and may trade in any of the designated investments mentioned herein either for their own account or the accounts of their customers, in good faith or in the normal course of market making. Accordingly, Canaccord Genuity or their affiliated companies, principals or employees (other than the authoring analyst(s) who prepared this research) may at any time have a long or short position in any such designated investments, related designated investments or in options, futures or other derivative instruments based thereon. Some regulators require that a firm must establish, implement and make available a policy for managing conflicts of interest arising as a result of publication or distribution of research. This research has been prepared in accordance with Canaccord Genuity s policy on managing conflicts of interest, and information barriers or firewalls have been used where appropriate. Canaccord Genuity s policy is available upon request. The information contained in this research has been compiled by Canaccord Genuity from sources believed to be reliable, but (with the exception of the information about Canaccord Genuity) no representation or warranty, express or implied, is made by Canaccord Genuity, its affiliated companies or any other person as to its fairness, accuracy, completeness or correctness. Canaccord Genuity has not independently verified the facts, assumptions, and estimates contained herein. All estimates, opinions and other information contained in this research constitute Canaccord Genuity s judgement as of the date of this research, are subject to change without notice and are provided in good faith but without legal responsibility or liability. Canaccord Genuity s salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients and our proprietary trading desk that reflect opinions that are contrary to the opinions expressed in this research. Canaccord Genuity s affiliates, principal trading desk, and investing businesses may make investment decisions that are inconsistent with the recommendations or views expressed in this research. This research is provided for information purposes only and does not constitute an offer or solicitation to buy or sell any designated investments discussed herein in any jurisdiction where such offer or solicitation would be prohibited. As a result, the designated investments discussed in this research may not be eligible for sale in some jurisdictions. This research is not, and under no circumstances should be construed as, a solicitation to act as a securities broker or dealer in any jurisdiction by any person or company that is not legally permitted to carry on the business of a securities broker or dealer in that jurisdiction. This material is prepared for general circulation to clients and does not have regard to the investment objectives, financial situation or particular needs of any particular person. Investors should obtain advice based on their own individual circumstances before making an investment decision. To the fullest extent permitted by law, none of Canaccord Genuity, its affiliated companies or any other person accepts any liability whatsoever for any direct or consequential loss arising from or relating to any use of the information contained in this research. For Canadian Residents: This research has been approved by Canaccord Genuity Corp., which accepts sole responsibility for this

AUS Update 6 For United States Residents: For United Kingdom and European Residents: For Jersey, Guernsey and Isle of Man Residents: For Australian Residents: For Singapore Residents: For Hong Kong Residents: research and its dissemination in Canada. Canadian clients wishing to effect transactions in any designated investment discussed should do so through a qualified salesperson of Canaccord Genuity Corp. in their particular province or territory. Canaccord Genuity Inc., a US registered broker-dealer, accepts responsibility for this research and its dissemination in the United States. This research is intended for distribution in the United States only to certain US institutional investors. US clients wishing to effect transactions in any designated investment discussed should do so through a qualified salesperson of Canaccord Genuity Inc. Analysts employed outside the US, as specifically indicated elsewhere in this report, are not registered as research analysts with FINRA. These analysts may not be associated persons of Canaccord Genuity Inc. and therefore may not be subject to the NASD Rule 2711 and NYSE Rule 472 restrictions on communications with a subject company, public appearances and trading securities held by a research analyst account. This research is distributed in the United Kingdom and elsewhere Europe, as third party research by Canaccord Genuity Limited, which is authorized and regulated by the Financial Conduct Authority. This research is for distribution only to persons who are Eligible Counterparties or Professional Clients only and is exempt from the general restrictions in section 21 of the Financial Services and Markets Act 2000 on the communication of invitations or inducements to engage in investment activity on the grounds that it is being distributed in the United Kingdom only to persons of a kind described in Article 19(5) (Investment Professionals) and 49(2) (High Net Worth companies, unincorporated associations etc) of the Financial Services and Markets Act 2000 (Financi al Promotion) Order 2005 (as amended). It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. This material is not for distribution in the United Kingdom or elsewhere in Europe to retail clients, as defined under the rules of the Financial Conduct Authority. This research is sent to you by Canaccord Genuity Wealth (International) Limited (CGWI) for information purposes and is not to be construed as a solicitation or an offer to purchase or sell investments or related financial instruments. This research has been produced by an affiliate of CGWI for circulation to its institutional clients and also CGWI. Its contents have been approved by CGWI and we are providing it to you on the basis that we believe it to be of interest to you. This statement should be read in conjunction with your client agreement, CGWI's current terms of business and the other disclosures and disclaimers contained within this research. If you are in any doubt, you should consult your financial adviser. CGWI is licensed and regulated by the Guernsey Financial Services Commission, the Jersey Financial Services Commission and the Isle of Man Financial Supervision Commission. CGWI is registered in Guernsey and is a wholly owned subsidiary of Canaccord Genuity Group Inc. This research is distributed in Australia by Canaccord Genuity (Australia) Limited ABN 19 075 071 466 holder of AFS Licence No 234666. To the extent that this research contains any advice, this is limited to general advice only. Recipients should take into account their own personal circumstances before making an investment decision. Clients wishing to effect any transactions in any financial products discussed in the research should do so through a qualified representative of Canaccord Genuity (Australia) Limited. Canaccord Genuity Wealth Management is a division of Canaccord Genuity (Australia) Limited. This research is distributed pursuant to 32C of the Financial Advisers under an arrangement between each of the Canaccord Genuity entities that publish research and Canaccord Genuity Singapore Pte. Ltd who are an exempt financial adviser under section 23(1)(d) of the Financial Advisers Act. This research is only intended for persons who fall within the definition of accredited investor, expert investor or institutional investor as defined under section 4A of the Securities and Futures Act It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. Recipients of this report can contact Canaccord Genuity Singapore Pte. Ltd. (Contact Person: Tom Gunnersen s tel # is +852 3919 2561) in respect of any matters arising from, or in connection with, the [analyses or report]. This research is distributed in Hong Kong by Canaccord Genuity (Hong Kong) Limited who is licensed by the Securities and Futures Commission. This research is only intended for persons who fall within the definition of professional investor as defined in the Securities and Futures Ordinance. It is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. Recipients of this report can contact Canaccord Genuity (Hong Kong). Ltd. (Contact Person: Tom Gunnersen s tel # is +852 3919 2561) in respect of any matters arising from, or in connection with, the research. Additional information is available on request. Copyright Canaccord Genuity Corp. 2014. Member IIROC/Canadian Investor Protection Fund Copyright Canaccord Genuity Limited 2014. Member LSE, authorized and regulated by the Financial Conduct Authority. Copyright Canaccord Genuity Inc. 2014. Member FINRA/SIPC Copyright Canaccord Genuity (Australia) Limited 2014. Participant of ASX Group, Chi-x Australia and of the NSX. Authorized and regulated by ASIC. All rights reserved. All material presented in this document, unless specifically indicated otherwise, is under copyright to Canaccord Genuity Corp., Canaccord Genuity Limited, Canaccord Genuity Inc. or Canaccord Genuity Group Inc. None of the material, nor its content, nor any copy of it, may be altered in any way, or transmitted to or distributed to any other party, without the prior express written permission of the entities listed above.